Aarden Pharmaceuticals

United States
Indianapolis, Indiana, United States
3172784102 ★

Company profile

Aarden Pharmaceuticals company profile

Aarden Pharmaceuticals is a small molecule drug discovery and development company. The company’s novel technology is a chemistry breakthrough that will enable it to make drugs against a previously un-druggable set of intracellular phosphatase (PTP) disease targets. The technology was developed in the laboratory of Dr. Zhong-Yin Zhang, Robert A. Harris Professor and chairman of biochemistry and molecular biology at the Indiana University School of Medicine. Zhang is an internationally recognized expert in the field of protein tyrosine phosphatases (PTPs). Aarden’s first programs are focused on infectious disease, cancer, and metabolic and autoimmune conditions.

Business identity

Contact email
[email protected]
Phone number
3172784102
Operating status
Closed
Company type
For Profit
Employee range
00001-00010 employees
Founded
2008-01-01

Headquarters

Headquarters
Indianapolis, Indiana, United States
Postal code
46202
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$500K
Last funding
Seed / $500K / 2011-01-03
Last equity funding
Seed / $500K
Investors
1
Founders
3
Closed on
2013-03-14

Founders and investors

Founders

Christopher LeMastersThomas M. EstokZhong-Yin Zhang

Investors

IU Ventures

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.